Friday, October 10, 2025 7:03:08 PM
Worked for me. I gottem drinking cold pressed green juice
Recent GTBP News
- "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies • GlobeNewswire Inc. • 05/14/2026 02:55:00 PM
- A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology • GlobeNewswire Inc. • 05/14/2026 01:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:35 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/13/2026 09:18:43 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/30/2026 08:55:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 11:05:14 AM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:09 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:05:27 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/30/2026 10:12:20 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/21/2026 09:15:32 PM
- 5 Assets Securing the 2026 Material Cycle • GlobeNewswire Inc. • 01/16/2026 04:18:58 PM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (US) • 01/16/2026 01:00:00 PM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (Canada) • 01/16/2026 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/08/2026 09:19:06 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines • PR Newswire (US) • 12/19/2025 12:55:00 PM
- Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines • PR Newswire (Canada) • 12/19/2025 12:55:00 PM
- Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 • PR Newswire (US) • 12/19/2025 12:44:00 PM
- Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 • PR Newswire (Canada) • 12/19/2025 12:44:00 PM
- 5 Companies Solving the Invisible Crisis • GlobeNewswire Inc. • 12/15/2025 03:54:35 PM
- Platform Technologies Drive $211B Surge in Precision Cancer Treatment • PR Newswire (Canada) • 12/11/2025 03:17:00 PM
- Platform Technologies Drive $211B Surge in Precision Cancer Treatment • PR Newswire (US) • 12/11/2025 03:17:00 PM
